Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins
Clinical trials sponsored by Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, explained in plain language.
-
DNA vaccine aims to wipe out HPV before it becomes cancer
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests an experimental DNA vaccine called pBI-11 in 48 women with persistent HPV16 or HPV18 infection. The vaccine is designed to boost the immune system to clear the virus, which can cause cervical cancer. Participants receive either the vaccine or a placebo via a spec…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 03:28 UTC
-
New surgical combo aims to reduce leakage risk in pancreatic cancer patients.
Disease control Not yet recruitingThis study looks at a procedure called total pancreatectomy with islet autotransplantation (TPIAT) in 30 adults with pancreatic or nearby tumors who are at high risk for a leak after standard surgery. The goal is to see if removing the whole pancreas and transplanting the patient…
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 03:31 UTC
-
Could a new combo slash hormone therapy time for prostate cancer?
Disease control Not yet recruitingThis study tests whether adding a targeted radiation drug (177Lu-PSMA-617) to standard radiation allows men with high-risk prostate cancer to take hormone therapy for only 6 months instead of the usual 24 months. The goal is to see if the shorter hormone course is just as effecti…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 03:29 UTC
-
Experimental vaccine combo targets rare liver cancer in early trial
Disease control Not yet recruitingThis early-phase study tests a combination of a personalized vaccine (targeting a specific cancer protein) with three other drugs for people with advanced fibrolamellar liver cancer that has worsened despite prior treatment. The goal is to see if the combination is safe and can s…
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New drug may tame dangerous immune overreaction after cancer treatment
Disease control Not yet recruitingThis early study tests the drug ruxolitinib for a rare but serious inflammatory condition called IEC-HS that can happen after CAR-T cell therapy for cancer. Sixteen adults will take the drug twice daily for up to 8 weeks. Researchers will check if the treatment helps control the …
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug cocktail aims to shrink rectal tumors before surgery
Disease control Not yet recruitingThis study tests whether adding immunotherapy drugs (cemiplimab alone or with fianlimab or REGN7075) to standard chemotherapy (CAPOX) can eliminate or shrink rectal cancer before surgery. About 66 adults with a specific type of rectal cancer (MSS, locally advanced) who have not h…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New combo therapy aims to shrink tough rectal tumors before surgery
Disease control Not yet recruitingThis study tests whether adding an experimental drug (DCSZ11) to standard radiation and chemotherapy can improve outcomes for people with a high-risk type of rectal cancer. About 30 adults with mismatch repair proficient (pMMR) locally advanced rectal cancer will receive the comb…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Healing harmonies: music therapy tested for brain tumor patients
Symptom relief Not yet recruitingThis study will test if virtual music therapy is practical and helpful for people newly diagnosed with glioblastoma, a serious brain cancer. Researchers will enroll 35 patients who have completed standard treatment. The goal is to see if music therapy can improve well-being durin…
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Symptom relief
Last updated May 20, 2026 11:58 UTC